TRIM58 and non-small cell lung carcinoma: Our study provided novel theory of ZEB1 expression modulation by TRIM58 via UPP (Figure 7), indicating TRIM58-triggered ZEB1 depletion via UPP might also serve as a potential treatment strategy in NSCLC patients.